REDWOOD CITY, Calif. (AP) _ Heron Therapeutics Inc. (HRTX) on Thursday reported a loss of $33.4 million in its first quarter.
On a per-share basis, the Redwood City, California-based company said it had a loss of 92 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 98 cents per share.
Heron Therapeutics shares have declined 30 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $18.66, an increase of 68 percent in the last 12 months.
On a per-share basis, the Redwood City, California-based company said it had a loss of 92 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 98 cents per share.
Heron Therapeutics shares have declined 30 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $18.66, an increase of 68 percent in the last 12 months.